Abiochem Biotechnology is a high-tech enterprise with leading enzyme engineering technology and genetic engineering technology. Engaged in the research and development of biocatalytic and synthetic biology methods, and is committed to its application to large-scale production. It is widely used in the fields of medicine, health care products, pesticides, etc., and has contributed to the promotion and development of green chemistry.

Momenta Pharmaceuticals, Inc. is a biotechnology company specializing in the characterization and process engineering of complex molecules. These complex molecules include proteins, polypeptides, and cell surface polysaccharides, such as heparan-sulfate proteoglycans. This results in a diversified product pipeline of complex generic, follow-on biologic and novel drugs. The Company's two most advanced complex generic product candidates target marketed products, which were originally approved by the United States Food and Drug Administration as New Drug Applications. M-Enoxaparin is designed to be a generic version of Lovenox (enoxaparin sodium injection), a low-molecular weight heparin used to prevent and treat deep vein thrombosis. Its second major generic product candidate is M356, a generic version of Copaxone (glatiramer acetate injection), a drug that is indicated for the reduction of the frequency of relapses in patients with relapsing-remitting multiple sclerosis.

Spagpo Nanomedical AB engages in the provision of research and development within nanomedicine. The firm focuses on the development of nanomaterials for tumor diagnostics and treatment of cancer. Its projects include SpagoPix and Tumorad. The company was founded on August 2, 1999 and is headquartered in Lund, Sweden.

Gambro Lundia AB operates as a medical technology company. It develops, manufactures, and distributes products and treatments for kidney and liver dialysis, treatment of myeloma kidney, and other extracorporeal treatments for chronically and acutely ill patients. The firm also holds shares in other companies. The company was founded on February 18, 1953 and is headquartered in Lund, Sweden.

The Max Planck Society for the Advancement of Science (German: Max-Planck-Gesellschaft zur Förderung der Wissenschaften e. V.; abbreviated MPG) is a non-governmental and non-profit association of Research Institutes publicly funded by the federal and the state governments of Germany. Additionally, the Max Planck Society and its Institutes receive third party funding from public and private contributions and from the European Union. The world leading organization is named in honor of its former president, theoretical physicist Max Planck. The 86 Institutes and Research Facilities of the Max Planck Society (as of 2020) conduct basic research in the natural sciences, life sciences, social sciences, and the arts and humanities. They have a total staff of approximately 24,000 permanent employees, including 15,000 scientists, and around 5,000 non-tenured scientists and guests. As of December 31, 2018, the proportion of female employees was 44.4 percent. The Max Planck Society (with its 86 Max Planck Institutes) has a world-leading reputation as a science and technology research organization, with more than 33 Nobel Prizes awarded to its scientists, and is widely regarded as one of the foremost basic research organizations in the world.

Part of Zhejiang Huahai Pharmaceutical Co., Ltd., Changxing Pharmaceutical Co., Ltd. is a Chinese company located in Changxing that manufactures and distributes pharmaceutical products. It was acquired by Zhejiang Huahai Pharmaceutical Co., Ltd. on April 29, 2015 for $16.76 million.

Hunan Pilot Biotechnology Co., Ltd., established on 2017-02-21, Business scope includes technology development in the biological field,Technical cooperation,technology transfer,technical consulting,Technical Services;Biological product,Chemical raw materials and products(Does not contain hazardous chemicals)purchase and sale;biological enzyme preparation,Research on fine chemical products,Production,Sales;import and export laws,Biological products allowed by regulations and policies;And provide technical promotion,consultation service;Feed additives,Production and sales of mixed feed additives;Technology development of pharmaceuticals and their intermediates,Technical cooperation,technology transfer,technical consulting,Technical Services;Development of raw materials and pharmaceutical intermediates,Production,Sales;Purchase and sale of related raw and auxiliary materials,Equipment Accessories.(Items subject to approval by law,Business activities can only be carried out after approval by relevant departments)

Wilmar (Shanghai) Biotechnology R&D Center Co., Ltd., established on 2002-12-10, The business scope includes research and development of enzymes and enzyme preparations and application technologies,Research and development of biopesticide products,Processing of edible oil and other fats and oils,R&D of Applied Technology,plant,Research and development of deep processing technology of agricultural and sideline products and related products,food additives,Food Safety and Other Related Foods,Beverage research and development,Research and development of bioenergy technology and related products,Transfer of own technological achievements,And provide technical consultation and services related to the above business;Provide services for group investment companies and affiliated companies(rental oil tank,storehouse,office building,Industrial Facility Maintenance,sewage treatment,Logistic support, etc.)and related management.[Items subject to approval by law,Business activities can only be carried out after approval by relevant departments]

Merck Sharp & Dohme Corp. engages in the research, development, and distribution of vaccines, prescription drugs, and animal health products. The company is headquartered in Whitehouse Station, NJ.

Hoechst AG produced specialty chemicals and pharmaceutical products. It products ranged in areas of heart cycle, thrombose, central nervous system, onkologie, diabetes, metabolic illnesses, internal medicine and vaccines. Founded in 1863, the company was headquartered in Frankfurt am Main, Germany.

Founded in 1980, Unigene is a publicly traded biopharmaceutical company with corporate offices, an R&D facility and a state-of-the-art recombinant manufacturing facility in New Jersey. There broad experience in molecular biology, protein chemistry, immunology and formulation development combined with there entrepreneurial spirit and innovation have led to the development of proprietary technologies, protected by a strong patent portfolio, enabling the commercialization of peptide drugs.

Part of Asymchem Laboratories (Tianjin) Co., Ltd., Asymchem Life Science Tianjin Co. Ltd. is a Chinese company located in Tianjin. The firm manufactures pharmaceutical raw materials. Yi Xiao is the current CEO, occupying that position since 2018.

Engages in developing, producing and selling pharmaceutical and chemical products

Shanghai Banglin Biotechnology Co., Ltd., established on 2021-01-22, Business scope includes general items:Engaged in technology development in the field of biotechnology,technology transfer,Technical Services,technical consulting;Sales of bio-based materials;Specialty Chemicals Sales(Free of Hazardous Chemicals);Chemical product sales(No licensed chemical products)(Except for projects subject to approval by law,Carry out business activities independently in accordance with the law with a business license).licensed items:Import and export;Technology Import and Export(Items subject to approval by law,Business activities can only be carried out after approval by relevant departments,The specific business items are subject to the approval documents or licenses of relevant departments).

Huzhou Yisheng Biotechnology Co., Ltd., established on 2020-03-11, Business scope includes general items:Biochemical product technology research and development;Manufacturing of Specialty Chemical Products(Free of Hazardous Chemicals);Sales of new catalytic materials and additives;Technical Services,technology development,technical consulting,Technology Exchange,technology transfer,Technology Promotion;R&D of industrial enzyme preparations;Fermentation process optimization technology research and development(Except for projects subject to approval by law,Carry out business activities independently in accordance with the law with a business license).licensed items:pharmaceutical production;Health food sales(Items subject to approval by law,Business activities can only be carried out after approval by relevant departments,Specific business projects are subject to approval results).

Novozymes is a world leader in bioinnovation. Novozymes works with its partners to innovate new solutions and rethink industries around the world. Novozymes' industrial enzymes, microorganisms, biopolymers, and other proteins allow its customers to achieve more efficient use of raw materials, reduce energy consumption, replace traditional chemicals with more sustainable alternatives, and offer higher-quality products. Novozymes rethinks everyday products every day.

Shandong Lukang Pharmaceutical Co., Ltd. engages in the development, production, and sale of pharmaceutical products. Its products include antibiotics, amino acids, cardiovascular and cerebrovascular, semi-synthetic antibiotics raw materials, biological drugs, infusion, proprietary Chinese medicines, pharmaceutical intermediates, animal health antibiotics, starch, and glucose. The company was founded in 1966 and is headquartered in Jining, China.

Asymchem Laboratories (Tianjin) Co., Ltd. engages in the research and development, and production of intermediates, and active pharmaceutical ingredients. Its business scopes include small molecule contract development and manufacturing organization (CDMO), and emerging service businesses. Its Small Molecule CDMO business provides process development and analysis, clinical drug production, new drug application and approval services, and current good manufacturing practice commercial production services. Its Emerging Service business covers chemical macromolecules, formulations, biosynthesis technology, biological macromolecules, and clinical research services. The company was founded by Hao Hong on October 7, 1998 and is headquartered in Tianjin, China.

Stella Chemifa Corp. engages in the manufacture, supply, and sale of high-purity chemicals. It operates through the following segments: High-Purity Chemical, Transportation, Medical, and Other. The High-Purity Chemical segment manufactures and sells high-purity chemicals such as fluoride. The Transportation segment deals with transporting and storing chemicals and manages custom clearance. The Medical segment handles the research and development of pharmaceuticals. The Other segment includes insurance agency and automobile maintenance businesses. The company was founded by Jisaburo Hashimoto on February 1, 1916 and is headquartered in Osaka, Japan.

Hangzhou Xinhai Enzyme Source Biotechnology Co., Ltd., established on 2020-11-23, Business scope includes general items:R&D of industrial enzyme preparations;Technical Services,technology development,technical consulting,Technology Exchange,technology transfer,Technology Promotion;Specialty Chemicals Sales(Free of Hazardous Chemicals)(Except for projects subject to approval by law,Carry out business activities independently in accordance with the law with a business license).